Investing

Novo Nordisk : NVO

NVO

Stock Data

$48.86

$0.03 (0.06%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

All Novo Nordisk Articles

166 Articles

Joel South | 9 hours ago

3 High Growth GLP-1 Biotech Winners to Buy in July

The GLP-1 trade has matured from a single-stock story into a tiered opportunity set. Demand for obesity therapeutics keeps expanding…

Joel South | Jul 7, 2026 at 8:30 AM EDT

2 Dirt Cheap Healthcare Stocks to Buy in July

Healthcare has become Wall Street’s bargain bin in 2026, and value hunters are starting to pay attention. Drug pricing reform,…

Omor Ibne Ehsan | Jul 6, 2026 at 3:15 PM EDT

The Anti-Magnificent Seven Trade? VGK Is Quietly Creeping Toward Record Highs

European stocks are having their loudest year in a decade, and the Vanguard FTSE Europe ETF (NYSEARCA:VGK) is the vehicle…

Rich Duprey | Jun 30, 2026 at 9:38 AM EDT

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from Silicon Valley. Biotechnology…

Alex Sirois | Jun 23, 2026 at 1:55 PM EDT

Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Everyone is still arguing about Novo Nordisk (NYSE:NVO | NVO Price Prediction), the Danish obesity juggernaut whose GLP-1 franchise turned…

Joel South | Jun 17, 2026 at 3:20 PM EDT

3 Beaten-Down Stocks That Could Roar Back in June

June is shaping up as a stock-picker’s month. Spring volatility has settled, and contrarian investors are scanning the wreckage for…

Joel South | Jun 13, 2026 at 9:30 AM EDT

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care…

Vandita Jadeja | Jun 11, 2026 at 2:58 PM EDT

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Novo Nordisk (NYSE: NVO) reported Q1 2026 results that pulled the…

Jeremy Phillips | Jun 11, 2026 at 9:30 AM EDT

The GLP-1 stock nobody is pricing in isn’t a drugmaker

Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food…

Gerelyn Terzo | Jun 3, 2026 at 9:03 AM EDT

Live Nasdaq Composite: Markets Take a Breather amid Stellar AI Earnings Cycle

This article will be updated throughout the day, so check back often for more daily updates.  The markets are cradling…

Jeremy Phillips | Jun 3, 2026 at 8:38 AM EDT

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

Wells Fargo’s chief agriculture economist Dr. Michael Swanson told Bloomberg Businessweek on May 29 that GLP-1 weight-loss drugs (Ozempic, Wegovy,…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX | VKTX…

Vandita Jadeja | May 21, 2026 at 8:25 AM EDT

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5%…

Alex Sirois | May 18, 2026 at 1:55 PM EDT

Three Biotechs That Are Top Takeover Targets

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious:…

David Moadel | May 5, 2026 at 10:44 AM EDT

Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show

Eli Lilly (NYSE:LLY | LLY Price Prediction) received another bullish call from Wall Street. Barclays analyst Emily Field raised her…